Haleon shrugged off the cost of living crisis yesterday as the painkiller seller reaped the rewards of a flu outbreak at the start of the summer.
It said its annual sales would now be better than previously hoped thanks to shoppers swallowing 7.5 per cent price increases and sticking with the Sensodyne and Panadol maker.
Sales were helped by the easing of Covid curbs in China, which boosted demand for its medications, while a flu outbreak this spring saw consumers